Hyperpolarized 129Xe
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Bastiaan Driehuys
Overview
Hyperpolarized 129Xe is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Hyperpolarized 129Xe clinical trials
Explore related
Medical disclaimer. This page summarizes research about Hyperpolarized 129Xe for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.